What is a stock summary page? Click here for an overview.
Business Description
Rekah Pharmaceutical Prod Ltd
ISIN : IL0010810096
Compare
Compare
Traded in other countries / regions
REKA.Israel IPO Date
2002-08-12Description
Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | 2.84 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.36 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.8 | |||||
| 3-Year EBITDA Growth Rate | 9.3 | |||||
| 3-Year FCF Growth Rate | 35.4 | |||||
| 3-Year Book Growth Rate | -2.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.23 | |||||
| 9-Day RSI | 23.79 | |||||
| 14-Day RSI | 21.44 | |||||
| 3-1 Month Momentum % | -2.19 | |||||
| 6-1 Month Momentum % | -0.81 | |||||
| 12-1 Month Momentum % | 0.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.45 | |||||
| Quick Ratio | 0.93 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 135.12 | |||||
| Days Sales Outstanding | 138.49 | |||||
| Days Payable | 139.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 18.73 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.36 | |||||
| Operating Margin % | -1.81 | |||||
| Net Margin % | 1.93 | |||||
| FCF Margin % | 5.55 | |||||
| ROE % | 3.84 | |||||
| ROA % | 1.34 | |||||
| ROIC % | -1.31 | |||||
| 3-Year ROIIC % | 118.46 | |||||
| ROC (Joel Greenblatt) % | 5.78 | |||||
| ROCE % | 4.72 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.46 | |||||
| PE Ratio without NRI | 21.46 | |||||
| Price-to-Owner-Earnings | 3.79 | |||||
| PEG Ratio | 3.52 | |||||
| PS Ratio | 0.42 | |||||
| PB Ratio | 0.82 | |||||
| Price-to-Tangible-Book | 1.31 | |||||
| Price-to-Free-Cash-Flow | 7.55 | |||||
| Price-to-Operating-Cash-Flow | 5.06 | |||||
| EV-to-EBIT | 17.71 | |||||
| EV-to-EBITDA | 5.49 | |||||
| EV-to-Revenue | 0.81 | |||||
| EV-to-FCF | 14.55 | |||||
| Price-to-GF-Value | 0.68 | |||||
| Price-to-Projected-FCF | 0.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.75 | |||||
| Price-to-Graham-Number | 1.12 | |||||
| Earnings Yield (Greenblatt) % | 5.64 | |||||
| FCF Yield % | 13.48 | |||||
| Forward Rate of Return (Yacktman) % | 17.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rekah Pharmaceutical Prod Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 321.712 | ||
| EPS (TTM) (₪) | 0.54 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.92 | ||
| 3-Year Sortino Ratio | -1.12 | ||
| Volatility % | 33.19 | ||
| 14-Day RSI | 21.44 | ||
| 14-Day ATR (₪) | 0.237655 | ||
| 20-Day SMA (₪) | 11.941 | ||
| 12-1 Month Momentum % | 0.22 | ||
| 52-Week Range (₪) | 11.3 - 16.01 | ||
| Shares Outstanding (Mil) | 11.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rekah Pharmaceutical Prod Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rekah Pharmaceutical Prod Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rekah Pharmaceutical Prod Ltd Frequently Asked Questions
What is Rekah Pharmaceutical Prod Ltd(XTAE:REKA)'s stock price today?
The current price of XTAE:REKA is ₪11.59. The 52 week high of XTAE:REKA is ₪16.01 and 52 week low is ₪11.30.
When is next earnings date of Rekah Pharmaceutical Prod Ltd(XTAE:REKA)?
The next earnings date of Rekah Pharmaceutical Prod Ltd(XTAE:REKA) is .
Does Rekah Pharmaceutical Prod Ltd(XTAE:REKA) pay dividends? If so, how much?
Rekah Pharmaceutical Prod Ltd(XTAE:REKA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers